Bayer execs calm about compulsory licensing clauses
By Wang Xin | 皇冠体育app Daily | Updated: 2010-11-24 07:57
|
Display promoting Bayer's iconic over-the-counter aspirin. The company will invest about $4.2 billion in research this year. Provided to 皇冠体育app Daily |
Clauses in the latest revision of 皇冠体育app's patent law permitting compulsory licensing of patented medicines has triggered concern among some companies, but pharmaceutical and chemical giant Bayer is remaining calm.
Photo
